Determination of minimal dose of Lidocaine with Sufentanil‘s fixed dose in spinal anesthesia for cesarean section.
Phase 2
- Conditions
- Delivery by elective caesarean section.Delivery by elective caesarean section
- Registration Number
- IRCT201102071310N7
- Lead Sponsor
- Vice Chancellor for Research Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 126
Inclusion Criteria
Exclusion criteria: All patients who are not class I and II ASA; Patients not signed the informed consent; Patients with underlying disease; Patients with chronic pain or; Who have used analgesic medications in the past forty eight hours; Patients with abscess or local infection at the injection site; Severe agitation; Cerebral disorder; Severe psychological disorders and addiction;
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severity of pain. Timepoint: every three minute after procedure. Method of measurement: Visual analogue Scale.;Nausea and Vomiting. Timepoint: Two and twenty four hours postoperative. Method of measurement: have, or not have.
- Secondary Outcome Measures
Name Time Method Blood Pressure. Timepoint: Once before spinal then every three minute after procedure with Datascope, Model: Pse-420. Method of measurement: mm Hg.;Heart Rate. Timepoint: Once before spinal then every three minute after procedure with Datascope model: Pse-420. Method of measurement: Number per minute.